BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12667408)

  • 21. [A randomized clinical trial on comparison of weight-adjusted dose with low dose recombinant tissue-type plasminogen activator on Chinese patients with acute myocardial infarction].
    Jiang SL; Zhang Y; Ji XP; Zhang L; Song ZF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1102-5. PubMed ID: 16563280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of direct stenting on epicardial and myocardial perfusion in patients with acute ST segment elevation myocardial infarction.
    Gasior M; Gierlotka M; Pres D; Lekston A; Zebik T; Hawranek M; Tajstra M; Stasik-Pres G; Kalarus Z; Poloński L
    Kardiol Pol; 2007 May; 65(5):503-12; discussion 513-4. PubMed ID: 17577847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of new thrombolytic agents in myocardial infarction: a multicenter randomized trial (APSAC versus rt-PA)].
    Cassagnes J; Machecourt J; Bassand JP; Lusson JR; Wolf JE; Anguenot T; Maublant J; Fagret D; Cardot JC
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1593-9. PubMed ID: 1300957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
    Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study.
    Le May MR; Davies RF; Labinaz M; Sherrard H; Marquis JF; Laramée LA; O'Brien ER; Williams WL; Beanlands RS; Nichol G; Higginson LA
    Circulation; 2003 Nov; 108(21):2624-30. PubMed ID: 14597591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advantages of immediate coronary dilatation after thrombolysis using tissue-type plasminogen activator in acute myocardial infarction. A European Cooperative Group trial].
    Vahanian A
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():39-43. PubMed ID: 2973300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of outcomes of direct stenting versus stenting after balloon predilation in patients with acute myocardial infarction (DIRAMI).
    Gasior M; Gierlotka M; Lekston A; Wilczek K; Zebik T; Hawranek M; Wojnar R; Szkodzinski J; Piegza J; Dyrbus K; Kalarus Z; Zembala M; Polonski L
    Am J Cardiol; 2007 Sep; 100(5):798-805. PubMed ID: 17719323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of patency of infarct-related coronary artery on acute outcome in acute myocardial infarction patients undergoing urokinase therapy. Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Mar; 110(3):187-90. PubMed ID: 9594337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.
    Kastrati A; Mehilli J; Nekolla S; Bollwein H; Martinoff S; Pache J; Schühlen H; Seyfarth M; Gawaz M; Neumann FJ; Dirschinger J; Schwaiger M; Schömig A;
    J Am Coll Cardiol; 2004 Mar; 43(5):734-41. PubMed ID: 14998609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2008; 14(1):131-41. PubMed ID: 19156043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of distal protection with the GuardWire Plus during primary angioplasty for acute myocardial infarction.
    Kawaguchi R; Hoshizaki H; Hiratsuji T; Seki R; Tada H; Adachi H; Toyama T; Naito S; Oshima S; Taniguchi K
    J Cardiol; 2005 Mar; 45(3):99-106. PubMed ID: 15801274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hospital results of salvage angioplasty with coronary stenting after failure of thrombolysis in the acute phase of myocardial infarction].
    Maillard L; Loose C; Desveaux B; Quilliet L; Delplace C; Fichaux O; Arwidson P; Pacouret G; Charbonnier B; Raynaud P
    Arch Mal Coeur Vaiss; 2000 Apr; 93(4):347-53. PubMed ID: 10816805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
    Chen LY; Nichols WW; Mattsson C; Teger-Nilson AC; Wallin R; Saldeen TG; Mehta JL
    Cardiovasc Res; 1995 Dec; 30(6):866-74. PubMed ID: 8746200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
    Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ
    Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reperfusion therapy in acute myocardial infarction today: thrombolysis, balloon angioplasty and stenting].
    Motomiya T
    J Cardiol; 1998 Jan; 31(1):37-51. PubMed ID: 9488950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.